E Fund Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-11,194
Closed -$79.9K – 374
2024
Q2
$79.9K Sell
11,194
-13,643
-55% -$104K ﹤0.01% 308
2024
Q1
$166K Buy
24,837
+4,488
+22% +$30.9K 0.01% 355
2023
Q4
$132K Buy
+20,349
New +$131K 0.01% 296
2023
Q3
– Sell
-10,990
Closed -$154K – 324
2023
Q2
$154K Buy
10,990
+953
+9% +$16.2K 0.01% 288
2023
Q1
$188K Sell
10,037
-6,691
-40% -$110K 0.01% 308
2022
Q4
$230K Buy
16,728
+4,749
+40% +$72.7K 0.02% 278
2022
Q3
$229K Sell
11,979
-2,015
-14% -$36.7K 0.02% 278
2022
Q2
$214K Buy
13,994
+3,159
+29% +$46.7K 0.02% 292
2022
Q1
$221K Buy
+10,835
New +$221K 0.01% 276

Other funds holding CDMO

E Fund Management's CDMO Position: Q3 2024 in Review

E Fund Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 11,194 shares — an estimated $79.9K sold.

E Fund Management first reported a position in CDMO in Q1 2022 and held it in 9 quarters. The position peaked at $230K in Q4 2022. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • E Fund Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • E Fund Management sold 11,194 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $79.9K.
  • E Fund Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • E Fund Management's Avid Bioservices, Inc. Common Stock position peaked at $230K in Q4 2022.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.